Innoforce is a premier CDMO focusing on Advanced Therapy Medicinal Products (“ATMP”). We have developed comprehensive technology platforms to enable end-to-end manufacture of high-quality plasmid DNA, RNA, LNP, exosomes, viral vectors, and cell therapeutics. Our state-of-the-art facility is designed to meet the cGMP standards of the FDA, EMA, and NMPA. We have also implemented rigorous policies and procedures to safeguard our clients’ IP. Innoforce is led by an industry-seasoned management team with extensive experience leading multiple innovative products from development to commercialization in the US, EU, and China. Our goal is to accelerate the development and commercialization of innovative products globally.
With our expertise in process development and manufacturing, Innoforce can be a trusted partner from R&D through commercialization.